期刊文献+

硅烷偶联剂A171对含亚甲基蓝的二氧化硅@磷酸八钙载药颗粒性能的影响 被引量:5

Influence of Vinyltrimethoxysilane on Properties of Methylene Blue-loaded Silica@Octacalcium Phosphate as Drug Delivery
原文传递
导出
摘要 在改性的St?ber工艺中添加亚甲基蓝(MB,药物分子)和硅烷偶联剂A171(乙烯基三甲氧基硅烷)制备得到含MB的二氧化硅颗粒(二氧化硅-MB),并用改性的Pechini方法在其表面沉积磷酸八钙(OCP),制备得到具有核壳结构的二氧化硅-MB@OCP。A171的加入量对颗粒的物相、成分和核壳结构都有显著影响。MB的释放行为,包括释放量和单体/二聚体比例对A171添加量、壳层结构和p H值敏感。相比于二氧化硅-MB,二氧化硅-MB@OCP颗粒在磷缓冲液和模拟溶酶体缓冲液中的降解率都显著提高。 Methylene blue-loaded silica (silica-MB) particles were prepared by a modified St6ber process with MB and vinyltrimethoxysilane (A171). Silica-MB@OCP powders were obtained after the deposition of octacalcium phosphate (OCP) on the surface of silica-MB by a modified Peehini process. The addition of A171 during the sol-gel process affects the phases, constitutes and core-shell structure of samples. The addition amount of A171, core-shell structure and pH value of culture solution have effects on the release behaviors of MB, i.e., cumulative release and ratio of released MB monomers versus dimers. Unlike silica-MB, the degradation percents of silica-MB@OCP increase significantly in phosphate buffer saline and lysosome-like buffer.
出处 《硅酸盐学报》 EI CAS CSCD 北大核心 2016年第8期1213-1219,共7页 Journal of The Chinese Ceramic Society
基金 山东省自然科学基金项目(ZR2013EML008和ZR2012EMM016) 山东省高等学校科技计划项目(J11LD52) 山东省科技发展计划项目(2014GZX201008)
关键词 硅烷偶联剂 亚甲基蓝 vinyltrimethoxysilane methylene blue silica octacaleium phosphate drug carrier degradation
  • 相关文献

参考文献25

  • 1ZHANG S, CHU Z, YIN C, et al. Controllable drug release and simultaneously carrier decomposition of SiO2 drug composite nanoparticles [J]. J Am Chem Soc, 2013, 135(15): 5709-5716.
  • 2LAI C Y, BRIAN G T, DUSAN M J, et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules [J]. J Am Chem Soc, 2003, 125(15): 4451-4459.
  • 3GAI S L, YANG P P, LI C X, et al. Synthesis of magnetic, up-conversion luminescent, and mesoporous core-shell-structured nanocomposites as drug carriers [J]. Adv Funct Mater, 2010, 20(7): 1-7.
  • 4DU L, LIAO S, KHATIB H A, et al. Controlled-access hollow mechanized silica nanocontainers [J]. J Am Chem Soc, 2009, 131(42): 15136-15142.
  • 5TSYALKOVSKY V, BURTOVYY R, KLEP V, et al. Fluorescent nanoparticles stabilized by poly(ethylene glycol) containing shell for pH-triggered tunable aggregation in aqueous environment [J]. Langmuir, 2010, 26( 13): 10684-10692.
  • 6SCHLOSSBAUER A, KECHT J, BEIN T. Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica [J]. Angew Chem Int Ed, 2009, 48(17): 3092-3095.
  • 7SEO S H, KIM 13 M, JOE A, et al. NIR-light-induced surface-enhanced Raman scattering for detection and photothermal/photodynamic therapy of cancer cells using methylene blue-embedded gold nanorod@SiO2 nanocomposites [J]. Biomaterials, 2014, 35(10): 3309-3318.
  • 8AMARAL L, MIGUEL V, MONLNAR J. Antimicrobial activity of phenothiazines [J]. In Vivo, 2004, 18(6): 725-732.
  • 9SHEN D, YANG J, LI X, et al. Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres [J]. Nano Lett, 2014, 14(2): 923-932.
  • 10MITCHELL K K P, LIBERMAN A, KUMMEL A C, et al. Iron(III)-doped, silica nanoshells: A biodegradable form of silica [J]. J Am Chem Soc, 2012, 134(34): 13997-14003.

同被引文献567

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部